The therapeutic effect of ribavirin plus pegylated interferon in chronic hepatitis B and C

被引：0
|
作者：
Chien, Rong-Nan
Hu, Ching-Chih
Sheen, I-Shyan
Liaw, Yun-Fan
Yen, Cho-Li
Chang, Jia-Jang
机构：
[1] Chang Gung Mem Hosp, Liver Res Unit, Chilung, Taiwan
[2] Chang Gung Mem Hosp & Univ, Liver Res Unit, Taipei, Taiwan
来源：
HEPATOLOGY | 2006年 / 44卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
402
引用
收藏
页码：341A / 341A
页数：1
相关论文
共 50 条
  • [1] Pegylated interferon plus ribavirin in chronic hepatitis c
    Bruce R. Bacon
    Current Gastroenterology Reports, 2001, 3 (1) : 84 - 84
  • [2] Therapeutic effects of pegylated interferon plus ribavirin in chronic hepatitis C patients with occult hepatitis B virus dual infection
    Chen, Li-Wei
    Chien, Rong-Nan
    Yen, Cho-Li
    Chang, Jia-Jang
    Liu, Ching-Jung
    Lin, Chih-Lang
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 (02) : 259 - 263
  • [3] Pegylated interferon plus ribavirin versus non-pegylated interferon plus ribavirin for chronic hepatitis C - A cochrane systematic review
    Simin, M
    Brok, F
    Stimac, D
    Gluud, C
    Gluud, LL
    HEPATOLOGY, 2005, 42 (04) : 666A - 666A
  • [4] Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
    PN Rao
    Abraham Koshy
    Jacob Philip
    Narayanan Premaletha
    Joy Varghese
    Krishnasamy Narayanasamy
    Samir Mohindra
    Nitin Vikas Pai
    Manoj Kumar Agarwal
    Ashokna Konar
    Hasmukh B Vora
    World Journal of Hepatology, 2014, (07) : 520 - 526
  • [5] Pegylated interferon α-2b plus ribavirin for older patients with chronic hepatitis C
    Kainuma, Mosaburo
    Furusyo, Norihiro
    Kajiwara, Eiji
    Takahashi, Kazuhiro
    Nomura, Hideyuki
    Tanabe, Yuichi
    Satoh, Takeaki
    Maruyama, Toshihiro
    Nakamuta, Makoto
    Kotoh, Kazuhiro
    Azuma, Koichi
    Shimono, Junya
    Shimoda, Shinji
    Hayashi, Jun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (35) : 4400 - 4409
  • [6] Pegylated interferon α-2b plus ribavirin for older patients with chronic hepatitis C
    Mosaburo Kainuma
    Norihiro Furusyo
    Eiji Kajiwara
    Kazuhiro Takahashi
    Hideyuki Nomura
    Yuichi Tanabe
    Takeaki Satoh
    Toshihiro Maruyama
    Makoto Nakamuta
    Kazuhiro Kotoh
    Koichi Azuma
    Junya Shimono
    Shinji Shimoda
    Jun Hayashi
    World Journal of Gastroenterology, 2010, 16 (35) : 4400 - 4409
  • [7] Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
    Rao, P. N.
    Koshy, Abraham
    Philip, Jacob
    Premaletha, Narayanan
    Varghese, Joy
    Narayanasamy, Krishnasamy
    Mohindra, Samir
    Pai, Nitin Vikas
    Agarwal, Manoj Kumar
    Konar, Ashoknanda
    Vora, Hasmukh B.
    WORLD JOURNAL OF HEPATOLOGY, 2014, 6 (07) : 520 - 526
  • [8] Cochrane systematic review: pegylated interferon plus ribavirin vs. interferon plus ribavirin for chronic hepatitis C
    Simin, M.
    Brok, J.
    Stimac, D.
    Gluud, C.
    Gluud, L. L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 25 (10) : 1153 - 1162
  • [9] Factors influencing therapeutic response to pegylated interferon plus ribavirin in the different genotypes of chronic hepatitis C
    Heidari, Mehdi
    Bayani, Masomeh
    Bijani, Ali
    Roushan, Mohammad Reza Hasanjani
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2014, 5 (04) : 219 - 222
  • [10] Pegylated interferon plus ribavirin for genotype Ib chronic hepatitis C in Japan
    Kogure, Takayuki
    Ueno, Yoshiyuki
    Fukushima, Koji
    Nagasaki, Futoshi
    Kondo, Yasuteru
    Inoue, Jun
    Matsuda, Yasunori
    Kakazu, Eiji
    Yamamoto, Takeshi
    Onodera, Hiroyoshi
    Miyazaki, Yutaka
    Okamoto, Hiromasa
    Akahane, Takehiro
    Kobayashi, Tomoo
    Mano, Yutaka
    Iwasaki, Takao
    Ishii, Motoyasu
    Shimosegawa, Tooru
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (47) : 7225 - 7230
12345